FEATURE ARTICLES
In a Pharmaceutical Online Live discussion on building inspection-ready systems with digital documentation, panelists emphasized that AI can accelerate review, trend analysis, and inspection response, but only when governed, validated, and kept firmly under human quality oversight.
- June 2026 — CDMO Opportunities And Threats Report
- Reshoring Pressure Meets Manufacturing Reality
- CDMO Live Europe 2026: Partnerships For An Uncertain World
- Resilience, Risk, And Relationships: CDMO Live Europe 2026 Report
- Building AI Readiness Through Cross Collaboration
- Bayer Adds A Spine To Modularity For Scale Without Disruption
- 7 Facilities Pilot PreCheck for Faster Approval
PHARMA ONLINE WHITE PAPERS
-
Digital Solutions Enhance Pharmaceutical Manufacturing Performance
Personalised therapies and advanced technologies are reshaping manufacturing. Explore how intelligent automation can improve flexibility, strengthen data integrity, and accelerate production.
-
Global Regulatory Harmonization: Comparisons In Aseptic Barrier Systems4/20/2026
Compare global aseptic standards from the FDA, EMA, PIC/S, and WHO. Gain insights into how advanced barrier systems harmonize international requirements to ensure sterile product integrity and safety.
-
A Decision Focused Guide To Contamination Control From Design To Opening4/7/2026
Stop treating contamination control as a late-stage detail. Learn how making early, intentional design choices prevents startup delays and ensures your new cleanroom is ready for inspection.
-
Enabling Digital Twins With Computational Fluid Dynamics Modeling1/16/2025
Embrace the transformative power of predictive modeling and digital twin technology to optimize bioprocess efficiency, ensure product quality, and drive innovation in biopharmaceutical manufacturing.
-
When To Consider Material And Personnel Airlocks For Downflow Booths3/20/2026
Strategic use of airlocks in downflow booth design enhances pressure stability and containment. A risk-based approach ensures facility integration meets rigorous safety and compliance standards.
-
Innovation In Filtration3/18/2025
Filtration removes contaminants to ensure safety and is essential in various applications, from lab-scale tasks to GMP production. Explore how its simplicity and reliability make it indispensable.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Immuno-Oncology Biomarker Measurement With High Sensitivity And Speed
- Detection And Quantification Of Amorphous Content In Materials
- Alternative Two-Step Mixed-Mode Approach To A mAb Purification Process
- Using dSEC-7 Column For Separation And Length Determination Of mRNA
- Anaerobic Cultivation Processes Of Probiotic Bacteria
NEWSLETTER ARCHIVE
- 08.12.26 -- From Syringes To Storage: Advances In Pharmaceutical Packaging
- 08.12.26 -- The Future Of Virus Filtration Is Automated
- 08.11.26 -- When Innovation Meets Scale
- 08.11.26 -- June 2026 — CDMO Opportunities And Threats Report
- 08.11.26 -- Six Technical Insights Every Tablet Manufacturer Should Read
INDUSTRY NEWS
-
Let Your Voice Help Shape Pharma Manufacturing
Pharmaceutical Online hosts live virtual panels with industry experts on important topics and challenges, and we want to know what topics are important to you. Please consider taking a few minutes of your time to tell us what they are.
-
ISPE Announces 2026 FOYA Winners
These awards recognize pharmaceutical and biopharmaceutical manufacturing projects that demonstrate excellence across innovation, operations, supply chain, Pharma 4.0, and social impact.
-
Høeg In, Pazdur Out At The FDA
What an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.
-
9 Drugs Granted Fast Track By FDA's Voucher Program
With targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.
-
Leaders In The Excipient Market: Region And Type
Though North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Project Farma Acquires SimoTech To Expand Life Sciences Manufacturing Services8/12/2026
Project Farma, PerkinElmer's leading provider of Good Manufacturing Practice (GMP) manufacturing services, today announced it has entered into a definitive agreement to acquire SimoTech, a trusted provider of manufacturing automation and GMP IT solutions to the life sciences industry.
-
Bristol Myers Squibb Selects Houston For Major $2.3B Manufacturing Investment8/11/2026
Bristol Myers Squibb (NYSE:BMY) today announced the selection of Houston, Texas, as the site for a new, state-of-the-art multi-modal manufacturing campus, representing an approximately $2.3 billion investment designed to accelerate the delivery of next-generation medicines to patients. The campus, at Generation Park in Houston, will create nearly 500 skilled jobs and is designed to grow in scale, capability and workforce for decades to come.
-
Harro Höfliger Expands European Footprint With New France Subsidiary8/10/2026
With a local team and expanded service capacities, the company is creating the conditions for even closer cooperation with its French customers.
-
STERIS To Invest $600 Million To Build Center Of Excellence In North Carolina8/6/2026
STERIS plc today announced that it will be investing $600 million to build a formulated chemistries manufacturing and distribution Center of Excellence in North Carolina, near the Raleigh-Durham Research Triangle region. The facility will serve as a central hub to produce high-performance infection prevention and contamination control chemistries used across the Healthcare and Pharmaceutical industries.
-
BeOne Committing $1 Billion+ To U.S. Drug Manufacturing Growth8/4/2026
BeOne Medicines, Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced a $300 million expansion of its flagship clinical and commercial-stage manufacturing and research and development center at the Princeton West Innovation Campus in Hopewell, New Jersey, bringing total U.S. manufacturing investment to more than $1 billion. The expansion will increase BeOne's production capacity to manufacture its medicines and is expected to create approximately 120 new full-time jobs. The investment supports the continued advancement of BeOne's deep oncology pipeline of more than 35 clinical and commercial-stage assets.